Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · NU SKIN ENTERPRISES, INC. (NUS)

Nu Skin says President of Global Sales Justin Keisel began medical leave August 17

Neutral Impact 3 of 5 leadership Written later

Effective August 17, 2026, Nu Skin said Justin Keisel, its Executive Vice President and President of Global Sales, began a medical leave of absence. Chayce Clark, the company's Executive Vice President, Chief Operating Officer and Chief Legal Officer, will lead Mr. Keisel's organization during his absence. The filing does not state how long the leave will last, so shareholders have no stated return date for the sales leadership role.

Key points

  • Effective date of leave: August 17, 2026
  • Justin Keisel, EVP and President of Global Sales, began a medical leave of absence
  • Chayce Clark, EVP, COO and Chief Legal Officer, will lead Keisel's organization during the leave
  • Filing gives no expected duration or return date

The filing

CompanyNU SKIN ENTERPRISES, INC. (NUS)
Form8-K, current report
Filed with the SECAug 21, 2026, 4:06 PM ET
Accession number0001140361-26-034016

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:29 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 21, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.